Loader

Pathways

PathWhiz ID Pathway Meta Data

PW132585

Pw132585 View Pathway
metabolic

Celiprolol Drug Metabolism

Homo sapiens
Celiprolol is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Celiprolol passes through the liver and is then excreted from the body mainly through the kidney.

PW145596

Pw145596 View Pathway
drug action

Celiprolol Drug Metabolism Action Pathway

Homo sapiens

PW122302

Pw122302 View Pathway
metabolic

cellobiose biosynthesis

Bacillus velezensis MRC5958
The cellulase enzyme system consists of cellobiohydrolase, endoglucanase, and beta-glucosidase and has been extensively studied with respect to its biosynthesis, properties, mode of action, application, and, most recently, secretion mechanisms. A knowledge of the factors governing the biosynthesis and secretion of these enzymes at the molecular level will be useful in maximizing enzyme productivity in extracellular fluid.

PW122295

Pw122295 View Pathway
metabolic

Cellular Metabolism

Escherichia coli

PW132391

Pw132391 View Pathway
metabolic

Cenobamate Drug Metabolism

Homo sapiens
Cenobamate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Cenobamate passes through the liver and is then excreted from the body mainly through the kidney.

PW145655

Pw145655 View Pathway
drug action

Cenobamate Drug Metabolism Action Pathway

Homo sapiens

PW123987

Pw123987 View Pathway
metabolic

Central Carbon Metabolism 1594740445

actinobacillus succinogenes 130Z

PW122345

Pw122345 View Pathway
metabolic

Central Carbon Pathway and offshoots

Homo sapiens
Metabolic Biochemistry

PW126863

Pw126863 View Pathway
drug action

Cephalexin Action Pathway (New)

Streptococcus pneumoniae (strain ATCC BAA-255 / R6)
Cephalexin is a first-generation cephalosporin used to treat certain susceptible bacterial infections. These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections. Cephalexin is administered orally as either 250 mg or 500 mg capsules. These capsules can be given 1 to 4 times daily, usually administered for seven days. Cephalexin inhibits penicillin binding proteins. Penicillin binding proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls. Inhibition of this protein leads to upregulation of autolytic enzymes and inhibition of cell wall synthesis. Cephalexin eventually leads to cell death. Side effects of taking cephalexin include abdominal pain, diarrhea, dyspepsia, gastritis, nausea, vomiting, erythema multiforme, genital pruritus, vaginitis, vaginal discharge, candidiasis, thrombocytopenia, neutropenia, eosinophilia, arthralgia, arthropathy, and arthritis.

PW144684

Pw144684 View Pathway
drug action

Cephalexin Drug Metabolism Action Pathway

Homo sapiens